Ihr Warenkorb (0 Artikel)
We are a leading authority in microbiome research
We are a leading authority in microbiome research

The microbiome is of such significance that every year there are now more than 20,000 scientific papers published on the subject and the therapeutic approaches based on it. Through our close collaboration with leading scientific institutions and experts, we have succeeded in publishing groundbreaking research results (including The Lancet) and developing products to address problems such as irritable bowel syndrome.
Kijimea is now one of the world's leading companies in microbiome research.
Our Favourites
What our customers say
Fig. modeled on customers
Our scientific advisory board


Glatte Bast
Assistant & Intestinal Expert

Jürgen Gschossmann, MBA
of Internal Medicine

HEINER KRAMMER

Martin Storr, MHBA


Glatte Bast
Assistant & Intestinal Expert

Jürgen Gschossmann, MBA
of Internal Medicine

HEINER KRAMMER

Martin Storr, MHBA
Glatte Bast
Assistant & Intestinal Expert
Jürgen Gschossmann, MBA
of Internal Medicine
HEINER KRAMMER
Martin Storr, MHBA
About Us
Our philosophy

We also conduct research into highly prevalent conditions, such as allergies, obesity and psoriasis. All of our products are based on microculture strains which have undergone extensive scientific research.
We maintain long-term, close and personal collaborations with leading institutions and microbiome researchers worldwide.

We develop products in an easy-to-take form which can be straightforwardly integrated into everyday routines – so people can live better and enjoy life more.

Each batch is individually approved for release based on independent laboratory tests.
Up to 20 performance and quality parameters are tested for each product. Production takes place in GMP-certified facilities.

Behind this lies the huge community of bacteria in our intestines. More than 20,000 scientific papers per year now look into the microbiome and the therapeutic approaches based on it.
Through our close collaboration with leading scientific institutions and experts, we have succeeded in publishing groundbreaking research results (including The Lancet) and developing products to addrerss problems such as irritable bowel syndrome and allergies.
Kijimea is now one of the world's leading companies in microbiome research.